Image

Cognitive Functioning in Adults With Somatic Diseases and General Population From a Biopsychosocial Perspective

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The goal of this observational study is to investigate cognitive functioning profiles in adults with neurologically recognized aphasic syndromes and general population.

The study group consist of minimal 600 adults (over 18 y.o.) who will be examined by qualified diagnosticians. Participants will be evaluated with tasks related to the studied variables: memory, learning and language. Furthermore informations regarding past and present health condition will be collected from participants.

The main questions it aims to answer are:

  1. What is the profile of memory and learning among polish adults?
  2. Do gender and age moderates patterns of memory and learning functioning among polish adults?
  3. What is a specific pattern of language functioning in adults with neurologically recognized aphasic syndromes?
  4. Do gender moderates specific patterns of language functioning in adults with neurologically recognized aphasic syndromes?

Researchers will compare the following groups of adults:

  1. general population/control group
  2. with neurologically recognized aphasic syndromes
  3. seniors (over 60 y.o.)

Eligibility

Inclusion criteria for general population/control group:

  • age from 18 to 60 y.o.

Inclusion criteria for neurologically recognized aphasic syndromes

  • age above 18 y.o.
  • neurologically recognized aphasic syndromes

Inclusion criteria for seniors:

  • age above 60 y.o.

Exclusion criteria for general population/control group:

  • age less then 18 y.o.
  • neurologically recognized aphasic syndromes

Exclusion criteria for neurologically recognized aphasic syndromes

  • age less then 18 y.o.
  • no neurologically recognized aphasic syndromes

Exclusion criteria for seniors

  • age less then 60 y.o.
  • diseases of the nervous system, such as: stroke, craniocerebral trauma, neuroinfections, neurodegenerative diseases
  • mental disorders such as depression, psychotic disorders, anxiety disorders, addictions

Study details

Aphasia, Development, Human, Neuropathology

NCT06365658

Bartosz M. Radtke

29 April 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.